| Autor: |
Matveev BP, Gorbunova VA, Smirnova NB, Zhumagazin ZhD, Bukharkin BV, Orel NF |
| Jazyk: |
ruština |
| Zdroj: |
Urologiia i nefrologiia [Urol Nefrol (Mosk)] 1996 May-Jun (3), pp. 34-6. |
| Abstrakt: |
A 22% response rate was achieved in clinical trials of Russian drug cycloplatam in disseminated and hormone-resistant cancer of the prostate. In 80% of cases the drug has improved quality of life of patients with prostatic cancer stage III and IV. Antitumor effect and low toxicity make cycloplatam applicable in combined therapy of prostatic cancer. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
